Enanta Pharmaceuticals (ENTA) Cash & Equivalents Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -41.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.99% |
| Dec 31, 2025 | -55.62% |
| Sep 30, 2025 | -13.25% |
| Jun 30, 2025 | 25.26% |
| Mar 31, 2025 | -5.24% |
| Dec 31, 2024 | 111.23% |
| Sep 30, 2024 | -56.40% |
| Jun 30, 2024 | -62.41% |
| Mar 31, 2024 | -13.17% |
| Dec 31, 2023 | -5.42% |
| Sep 30, 2023 | 94.09% |
| Jun 30, 2023 | 235.52% |
| Mar 31, 2023 | 78.53% |
| Dec 31, 2022 | -57.38% |
| Sep 30, 2022 | -23.10% |
| Jun 30, 2022 | 516.54% |
| Mar 31, 2022 | -46.85% |
| Dec 31, 2021 | 79.81% |
| Sep 30, 2021 | -34.34% |
| Jun 30, 2021 | -95.39% |
| Mar 31, 2021 | 3.75% |
| Dec 31, 2020 | 99.92% |
| Sep 30, 2020 | 70.08% |
| Jun 30, 2020 | 6.00% |
| Mar 31, 2020 | -29.89% |
| Dec 31, 2019 | -62.94% |
| Sep 30, 2019 | -19.83% |
| Jun 30, 2019 | 121.78% |
| Mar 31, 2019 | 58.43% |
| Dec 31, 2018 | 9.28% |
| Sep 30, 2018 | -2.70% |
| Jun 30, 2018 | 90.80% |
| Mar 31, 2018 | 248.37% |
| Dec 31, 2017 | 230.07% |
| Sep 30, 2017 | 296.18% |
| Jun 30, 2017 | -10.19% |
| Mar 31, 2017 | -65.91% |
| Dec 31, 2016 | -55.40% |
| Sep 30, 2016 | -23.70% |
| Jun 30, 2016 | 24.92% |
| Mar 31, 2016 | 118.87% |
| Dec 31, 2015 | 35.46% |
| Sep 30, 2015 | -29.23% |
| Jun 30, 2015 | -24.76% |
| Mar 31, 2015 | 42.26% |
| Dec 31, 2014 | 671.13% |
| Sep 30, 2014 | 246.53% |
| Jun 30, 2014 | 39.71% |
| Mar 31, 2014 | -75.69% |
| Dec 31, 2013 | -78.65% |
| Sep 30, 2013 | -15.72% |
| Jun 30, 2013 | 376.60% |
| Mar 31, 2013 | 259.69% |